Table 4 Treatment differences across the pediatric age strata and between children and adults
Age strata patients | Children <5 years | Children 6–12 years | Adolescents 13–17 years | All aged <18 years | Adults ≥18 years | Altogether |
|---|---|---|---|---|---|---|
% on oral H1-blockers | 51.6 % | 54.0 % | 44.6 % | 50.0 % | 50.5 % | 50.3 % |
Significance | P = 0.188 | P = 0.861 | ||||
% on nasal steroids | 36.1 % | 55.7 % | 49.7 % | 47.6 % | 61.2 % | 57.1 % |
Significance | P = 0.001 | P = 0.000 | ||||
(a)% on decongestants | 0.0 % | 0.0 % | 0.6 % | 0.2 % | 1.5 % | 1.1 % |
Significance | P = 0.114 | P = 0.020 | ||||
% immuno-therapy | 8.4 % | 17.0 % | 20.6 % | 15.6 % | 9.8 % | 11.5 % |
Significance | P = 0.008 | P = 0.001 | ||||